Epidemiology of atrial fibrillation

被引:0
|
作者
Conen, David [1 ,2 ,3 ,4 ]
Osswald, Stefan [2 ]
Albert, Christine M. [3 ,4 ,5 ]
机构
[1] Univ Basel Hosp, Dept Med, CH-4031 Basel, Switzerland
[2] Univ Basel Hosp, Div Cardiol, CH-4031 Basel, Switzerland
[3] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Arrhythmia Prevent,Dept Med, Boston, MA 02115 USA
[4] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Prevent Med,Dept Med, Boston, MA 02115 USA
[5] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc,Dept Med, Boston, MA 02115 USA
关键词
atrial fibrill ation; epidemiology; bood pressure; inflammation; risk factors; C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; N-3; FATTY-ACIDS; 20-YEAR FOLLOW-UP; ALCOHOL-CONSUMPTION; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; RISK-FACTORS; PHYSICAL-ACTIVITY; INFLAMMATORY MARKERS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atrial fibrillation is the most common sustained cardiac arrhythmia in the general population. Unfortunately, current treatment strategies aiming at the elimination of atrial fibrillation have limited long term success rates and significant risks. In this context, recent publications have provided many insights on potentially treatable risk factors for the occurrence of atrial fibrillation, such as alcohol, blood pressure, obesity, inflammation and nutritional factors. In this review, we summarise the current evidence on these risk factors and indicate areas in need of further investigation. The current evidence shows that blood pressure, hypertension and obesity seem to play a key role in the pathogenesis of atrial fibrillation. Preliminary evidence also suggests that inflammation is an important mediator of these associations. Knowledge of these interrelationships may eventually help to develop new treatment strategies and decrease the burden of atrial fibrillation in the general population.
引用
收藏
页码:346 / 352
页数:7
相关论文
共 50 条
  • [31] Pathophysiology, epidemiology and complications of atrial fibrillation
    Perings, C
    Hennersdorf, M
    Vester, EG
    Weirich, J
    Strauer, BE
    INTERNIST, 1998, 39 (01): : 2 - 11
  • [32] Atrial fibrillation: epidemiology, prognosis and therapy
    Rutzen-Lopez, H.
    Khanna, V.
    Reynolds, M. R.
    MINERVA MEDICA, 2011, 102 (03) : 187 - 208
  • [33] Atrial fibrillation, epidemiology and association with stroke
    Kultursay, Hakan
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2013, 41 : 1 - 6
  • [34] Epidemiology, pathogenesis and genetics of atrial fibrillation
    Francisco Gudino, Alvaro
    Chediak, Cristina
    MEDWAVE, 2012, 12 (03):
  • [35] Erratum: Global epidemiology of atrial fibrillation
    Faisal Rahman
    Gene F. Kwan
    Emelia J. Benjamin
    Nature Reviews Cardiology, 2016, 13 : 501 - 501
  • [36] Stroke in atrial fibrillation: epidemiology and thromboprophylaxis
    Lip, G. Y. H.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 344 - 351
  • [37] ABC OF ATRIAL-FIBRILLATION - HISTORY, EPIDEMIOLOGY, AND IMPORTANCE OF ATRIAL-FIBRILLATION
    LIP, GYH
    BEEVERS, DG
    BRITISH MEDICAL JOURNAL, 1995, 311 (7016): : 1361 - 1363
  • [38] Epidemiology and management of atrial fibrillation in the community in Italy: the Italian Survey of Atrial Fibrillation Management
    Zoni-Berisso, M.
    Filippi, A.
    Landolina, M.
    Brignoli, O.
    Grimaldi, M.
    Maglia, G. P.
    Ermini, G.
    EUROPEAN HEART JOURNAL, 2012, 33 : 970 - 970
  • [39] Epidemiology and modifiable risk factors for atrial fibrillation
    Elliott, Adrian D.
    Middeldorp, Melissa E.
    Van Gelder, Isabelle C.
    Albert, Christine M.
    Sanders, Prashanthan
    NATURE REVIEWS CARDIOLOGY, 2023, 20 (06) : 404 - 417
  • [40] Atrial Fibrillation in Women: from Epidemiology to Treatment
    Tamirisa, Kamala P.
    Dye, Cicely
    Ekeruo, Ijeoma
    Volgman, Annabelle Santos
    CURRENT CARDIOVASCULAR RISK REPORTS, 2022, 16 (12) : 207 - 217